Skip to main content
. 2018 Jul 17;18(9):66. doi: 10.1007/s11892-018-1030-4

Table 1.

Adjustment of diabetes medication during multidisciplinary weight management in patients with type 2 diabetes and obesity

List A List B
Effect on body weight Weight gain Weight neutral Weight loss
Significant Modest
Pioglitazone Sulfonylureas
Glimepiride
Glipizide XL
Metformin GLP-1 analogs
Exenatide
Exenatide ER
Liraglutide
Albiglutide
Dulaglutide
Semaglutide
Sulfonylureas
 Glyburide
 Glipizide
Glinides
Repaglinide
Nateglinide
DPP-4 inhibitors
Sitagliptin
Saxaglipitin
Linagliptin
Alogliptin
Insulin
 NPH
 Glargine
 Regular
 Aspart
 Lispro
 Glulisine
Insulin
Detemir
Degludec
Glargine U-300
Glulisine (PP)
Aspart (PP)
α-Glucosidase inhibitors
Acarbose
Miglitol
Pramlintide
Colesevelam SGLT2-inhibitors
Canagliflozin
Dapagliflozin
Embagliflozin
Bromocriptine
Adjustments Stop, reduce, or switch Continue Add

PP postprandial